Taxotere resistance in SUIT Taxotere resistance in pancreatic carcinoma cell line SUIT 2 and its sublines
Open Access
- 1 January 2001
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 7 (6) , 855-859
- https://doi.org/10.3748/wjg.v7.i6.855
Abstract
AIM: To investigate the specific mechanisms of intrinsic and acquired resistance to taxotere (TXT) in pancreatic adenocarcinoma (PAC). METHODS: MTT assay was used to detect the sensitivity of PAC cell line SUIT-2 and its sublines (S-007, S-013, S-020, S-028 and TXT selected SUIT-2 cell line, S2/TXT) to TXT. Mdr1 (P-gp), multidrug resistance associated protein (MRP), lung resistance protein (LRP) and β-tubulin isotype gene expressions were detected by RT-PCR. The functionality of P-gp and MRP was tested using their specific blocker verapamil (Ver) and indomethacin (IMC), respectively. The transporter activity of P-gp was also confirmed by Rhodamine 123 accumulation assay. RESULTS: S-020 and S2/TXT were found to be significantly resistant to TXT (19 and 9.5-fold to their parental cell line SUIT-2, respectively). RT-PCR demonstrated strong expression of Mdr1 in these two cell lines, but weaker expression or no expression in other cells lines. MRP and LRP expressions were found in most of these cell lines. The TXT-resistance in S2-020 and S2/TXT could be reversed almost completely by Ver, but not by IMC. Flow cytometry showed that Ver increased the accumulation of Rhodamine-123 in these two cell lines. Compared with S-020 and SUIT-2, the levels of β-tubulin isotype II, III expressio ns in S-2/TXT were increased remarkably. CONCLUSION: The both intrinsic and acquired TXT-related drug resistance in these PAC cell lines is mainly mediated by P-gp, but had no relationship to MRP and LRP express ions. The increases of β-tubulin isotype II, III might be collateral changes that occur when the SUIT-2 cells are treated with TXT.Keywords
This publication has 56 references indexed in Scilit:
- Integration of new chemotherapeutic agents into chemoradiotherapy for stage III non-small cell lung cancer: Focus on docetaxelSeminars in Oncology, 2001
- The role of β-tubulin isotypes in resistance to antimitotic drugsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2001
- Expression of the Multidrug-Resistance 1 (MDR1) Gene and Prognosis in Human Pancreatic CancerPancreas, 2000
- A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinomaEuropean Journal Of Cancer, 2000
- A β-Tubulin Leucine Cluster Involved in Microtubule Assembly and Paclitaxel ResistanceJournal of Biological Chemistry, 1999
- Isolation of a taxol-resistantLeishmania donovanipromastigote mutant that exhibits a multidrug-resistant phenotypeFEMS Microbiology Letters, 1999
- Protein Kinase C Isoform Expression and Activity Alter Paclitaxel Resistancein VitroGynecologic Oncology, 1999
- Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven PolymerizationJournal of Biological Chemistry, 1997
- The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell linesPublished by Elsevier ,1996
- Characterization of the Taxol Binding Site on the MicrotubuleJournal of Biological Chemistry, 1995